Stay updated on Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page’s revision/version indicator has been updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T05:52:17.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:09:38.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The study EV-103 (NCT03288545) was terminated by the sponsor after meeting enrollment targets and primary objectives, with data collected for planned regulatory filings. The page updates recruitment status to reflect termination, including removal of the 'Active, not recruiting' designation and related dates.
    Difference
    0.2%
    Check dated 2026-03-26T04:01:41.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added revision: v3.5.0. Removed revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T23:58:55.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T18:36:45.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.4.2. The funding-lapse notice and the prior Revision: v3.4.1 text were removed.
    Difference
    0.2%
    Check dated 2026-02-11T09:41:47.000Z thumbnail image

Stay in the know with updates to Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin Combinations in Urothelial Cancer Clinical Trial page.